Valuation sounds like a math exam. It isn't. It answers one question: what do I get for the price I'm paying, and what does the market already expect? This guide goes from zero, one step at a time, using a made-up company so the numbers stay simple. Every number named below is on any free stock-quote site (Yahoo Finance, for example) under its valuation, financials and balance-sheet tabs.

Step 0 — The one idea everything rests on

When you buy a share, you're buying a tiny slice of a business. The price per share on its own tells you nothing. A $5 stock can be expensive and a $900 stock can be cheap.

What matters is the price of the whole company compared with what the whole company earns or sells.

Dummy rule #1: Never judge a stock by its share price. Judge it by market cap (or EV) compared with sales, profit or cash flow.

Step 1 — Work out which kind of tech company it is

Tech companies come in three stages, and each stage uses a different measuring stick. Using the wrong one is the #1 beginner mistake.

Stage What it looks like Main measuring stick
A. Mature & profitable Positive Net Income every year, growth 0–15% P/E, P/FCF
B. Fast grower, barely profitable or losing money Revenue growing 20%+, Net Income near zero or negative P/S (or EV/Sales) + quality checks
C. Story stock Tiny or no revenue, big losses, priced on a dream No ratio works. It's a bet on the story, so treat it like a biotech (see the companion article)

To check: look at Net Income and Rev Growth YoY on the stock page. Negative net income means P/E is meaningless, so skip it.

Step 2 — The four ratios, explained like you're five

P/E (Price / Earnings): for stage A

"How many years of today's profit am I paying for?"
- P/E 20 = you pay $20 for every $1 of yearly profit.
- Rough feel: around 15–25 is "normal" for a mature company, 40+ means the market expects strong growth, and under 10 means the market expects trouble (or it's a bargain; you have to find out which).

P/FCF (Price / Free Cash Flow): for stage A, and a cross-check for B

Free cash flow is the actual cash left over after running the business and paying for equipment. Earnings can be massaged with accounting. Cash is harder to fake. If P/E looks cheap but P/FCF is huge, be suspicious.

P/S (Price / Sales): for stage B

"How many dollars am I paying for each $1 of yearly revenue?"
- Used when there's no profit yet. P/S 10 = you pay $10 per $1 of sales.
- But sales aren't all equal. $1 of software revenue (80% gross margin) is worth far more than $1 of hardware revenue (30% gross margin). That's why Step 3 exists.

PEG (P/E ÷ growth rate)

P/E adjusted for growth. A P/E of 40 with 40% growth = PEG 1.0. Rough feel: under 1 is cheap for its growth, 1–2 is fair, and over 2 is expensive for its growth. It only works if the growth rate is real and lasts several years.

Step 3 — Quality checks: is the revenue worth paying up for?

Two companies can both trade at 10× sales, and one is a bargain while the other is a trap. These checks tell them apart.

1. Gross Margin: how much of each sales dollar is left after the direct cost of making the product.
- Software / SaaS: 70–85% is normal. Under 60% is a warning.
- Semiconductors: roughly 45–65% for strong designers, lower for manufacturers.
- Hardware / services: 20–40%.
- Rising gross margin = pricing power. That's the single best sign you can find.

2. Revenue growth, and whether it's speeding up or slowing down
- 30% growth that's speeding up beats 40% growth that's slowing down. The market pays for acceleration. (The screener's Rev Accel. filter on this site does exactly this check.)

3. The Rule of 40 (software only)
Revenue growth % + FCF margin % (or operating margin %) should be 40 or more.
- 30% growth + 15% FCF margin = 45 ✅
- 10% growth + 5% margin = 15 ❌ (slow and not very profitable)

4. Share count (dilution)
Compare Shares Out over time (the 10-K shows it). If shares grow 5%+ a year, your slice keeps shrinking. Tech companies often pay staff in stock (stock-based compensation, SBC). A company that's "profitable" only on an adjusted basis that ignores SBC isn't really profitable.

5. Balance sheet
Cash vs LT Debt. Lots of cash and little debt = it can survive a bad year. Losing money with little cash = it'll need to sell new shares (an offering), and the stock usually drops when it does.

Step 4 — Compare with peers, never in a vacuum

A P/S of 12 means nothing by itself. Put it next to 3–5 similar companies:

Our company Peer 1 Peer 2 Peer 3
P/S 12 8 15 10
Rev growth 35% 20% 40% 25%
Gross margin 78% 72% 80% 70%

Our company is priced in the middle but grows faster than two of the three peers, at a better margin than all but one. That's reasonable, not expensive. Valuation is always relative.

The screener (filter by industry) is the fastest way to build this table.

Step 5 — The pro move: work out what's already "priced in" (reverse valuation)

Beginners ask "what's it worth?" That's hard. Pros ask "what does the market already expect, and can the company beat it?" That's easy, and it's the most useful thing in this article.

Worked example: made-up company "CloudCo"
- Market cap: $20B
- Revenue this year: $1B, so P/S = 20
- Growing 30% a year

Question: if CloudCo matures in 5 years and trades at a normal 8× sales (typical for a solid, slower-growing software company), what revenue does it need just to keep today's price?

What it means:
- If you believe CloudCo can keep growing faster than 20%, today's price is reasonable and the stock can rise.
- If its growth is slowing toward 15%, the price already assumes too much, and even "good" earnings can make the stock fall.

That's the whole game: the stock moves when reality beats or misses what's priced in, not when the company is simply "good."

Napkin formula: (Market cap ÷ a fair mature multiple) = revenue needed. Compare it with today's revenue and you get the growth rate the market is betting on.

Step 6 — Traps that get beginners

  1. Cheap semis at the peak. Chip stocks are cyclical. At the top of the cycle profits are huge, so P/E looks low, right before profits collapse. At the bottom, P/E looks sky-high (or negative), and that's often the time to buy. For semis, a low P/E can be a sell signal.
  2. "Adjusted" earnings. Companies report "non-GAAP" numbers that leave out stock compensation and one-time costs. Check GAAP Net Income and Free Cash Flow too.
  3. One-time gains. A sold division or a tax benefit can make P/E look cheap for one year. If Net Income jumps but Op Cash Flow doesn't, dig into why.
  4. Cheap because it's dying. A P/E of 8 with shrinking revenue isn't a bargain. It's the market pricing in decline.
  5. TTM vs Forward. TTM = the last 12 months (real). Forward = analyst guesses for the next 12 months. For fast growers forward looks much cheaper, but it's only a guess.

Step 7 — The 5-minute checklist (print this)

  1. Stage? Profitable (P/E, P/FCF) or growing at a loss (P/S + quality)?
  2. Growth? Rev Growth YoY, and is it speeding up or slowing down?
  3. Quality? Gross margin level and trend, Rule of 40 (software), real FCF?
  4. Safety? Cash vs debt, shares outstanding rising?
  5. Relative? Its multiple vs 3–5 peers.
  6. Priced in? Market cap ÷ fair multiple → required growth. Is that believable?

How this fits a momentum / catalyst trader

You don't need valuation to time a trade. Momentum and catalysts do that. Valuation gives you context:
- Low expectations + a real catalyst (Step 5 shows modest growth priced in, then a big beat) = the move has room to run.
- Sky-high expectations = the stock needs perfect news. A small miss can gap it down hard.
- Don't veto a strong momentum setup just because the P/E is high. The best leaders almost always look expensive. Use valuation to size and to set expectations, not as a stop sign.
- The one hard flag: a money-losing company with little cash. A spike often brings a share offering. That's supply risk, not a valuation opinion.

Next: the companion article, How to Value a Biotech Stock, where none of these ratios work and you count cash and probabilities instead.